Granahan Investment Management ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 135 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Granahan Investment Management ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2021$3,540
-49.8%
293,766
-11.8%
0.07%
-48.9%
Q2 2021$7,045
-20.5%
333,085
+5.4%
0.13%
-30.3%
Q1 2021$8,862
-24.3%
315,920
-29.9%
0.19%
-28.5%
Q4 2020$11,710
-35.5%
450,398
-7.7%
0.26%
-57.3%
Q3 2020$18,143
+13.4%
488,099
+56.6%
0.62%
+6.6%
Q2 2020$15,997
+120.2%
311,776
+35.3%
0.58%
+47.8%
Q1 2020$7,266
-57.3%
230,454
-19.2%
0.39%
-50.1%
Q4 2019$17,014
+200.1%
285,327
+84.5%
0.78%
+151.0%
Q3 2019$5,669
+13.9%
154,628
+42.9%
0.31%
-11.4%
Q4 2018$4,977
+0.6%
108,200
-2.9%
0.35%
+31.3%
Q3 2018$4,945
+17.5%
111,450
+3.8%
0.27%
+5.9%
Q2 2018$4,207
+35.5%
107,350
-56.7%
0.25%
+136.4%
Q4 2016$3,105
-9.6%
248,0300.0%0.11%
-4.5%
Q3 2016$3,435
+40.1%
248,0300.0%0.11%
+25.8%
Q2 2016$2,451
-41.5%
248,030
+0.2%
0.09%
-41.4%
Q1 2016$4,187
-24.0%
247,6300.0%0.15%
-20.0%
Q4 2015$5,512
-22.0%
247,630
-17.3%
0.19%
-13.2%
Q3 2015$7,067
-67.9%
299,580
+11.1%
0.22%
-64.9%
Q2 2015$22,041
+2.3%
269,580
+15.8%
0.62%
+1.1%
Q1 2015$21,555232,7800.62%